USPTO serial 79154925
BTG
Reviewed by CopyMark Law Group
Reg. 4920036Status 709
- Filing date
- Status date
- Registration date
- Mar 22, 2016
- Examiner
- MIZELLE HOWARD, DEZMONA JULYE
- Law office
- —
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BTG?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jonathan A. Hyman
Jonathan A. Hyman Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorIrvine, CA 92614UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | [ Computer firmware for controlling medical devices; ] computer firmware for controlling and managing patient medical information; [ computer hardware; computer peripherals; computer software for use in medical devices, namely, software for the operation of medical devices and for analyzing the results of testing completed through medical devices; computer software for use in ultrasound devices, namely, software for the operation of ultrasound devices and for analyzing ultrasound images; ] computer software for medical monitoring, medical testing and patient evaluating programs; computer software for the diagnosis, treatment, and management of health conditions and illnesses; [ computer software for the diagnosis, assessment, treatment, management, and aftercare of conditions in the fields of sclerotherapy, phlebology, angiology, proctology and interventional oncology and emphysema; computer software for the diagnosis, assessment, treatment, management, and aftercare of tumors; computer software for the diagnosis, assessment, treatment, management, and aftercare of varicose veins, arterio-venous malformations, oesophageal varices, and hydroceles; computer software for the diagnosis, assessment, treatment, management and aftercare of emphysema; ] computer software for controlling and managing patient medical information; computer programs for controlling and managing patient medical information; computer programs for use in the field of health care for the collection, maintenance and management of data for patient records, clinical diagnosis and assessment, patient treatment, goals management, outcome analysis, scheduling, [ health care facilities management, materials management, ] resources utilization [, billing and accounting, and the review of health care facilities, services and clinical records* ; * ] [.] computer software for use by health care providers to analyze the outcomes of medical procedures and information relating to patient care; [ computer software for use in database management; computer database software for clinical use, clinical governance, clinical audit, collecting and analyzing information relating to patient demographics, procedures and outcomes; downloadable electronic publications in the nature of questionnaires on the subject of healthcare, medicine, medical treatment and patient care; ] downloadable electronic publications in the nature of patient reported outcome questionnaires on the subject of healthcare, medicine, medical treatment and patient care for use with a telecommunications device; downloadable software in the nature of a mobile application for handheld computers, mobile computer devices, mobile phones, and media players that provides access to information, advice and calculation tools in the fields of healthcare, medicine, medical treatment and patient care; computer software for use in monitoring and diagnosing biochemical reactions and phenomena; [ computer software for use in database management, namely, computer databases for clinical use, clinical governance, clinical audit, collecting and analysing information relating to patient demographics, procedures and outcomes; downloadable electronic questionnaires on the subject of healthcare, medicine, medical treatment and patient care; downloadable electronic patient reported outcome questionnaires; downloadable electronic patient reported outcome questionnaires for use with a telecommunications device; ] downloadable publications in electronic form, namely, [ journals, magazines, periodicals, ] articles [ and books ] in the fields of healthcare, the use of pharmaceuticals [ and medical devices ], medical research, [ surgery, ] medical science, medicine, patient care, medical diseases, disorders and related treatments* ; * [.] [ downloadable electronic publications, namely, journals, magazines, periodicals, articles and books provided on-line from databases or the internet in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, patient care, medical diseases, disorders and related treatments; electrically operated diagnostic testing apparatus and instruments, namely, electrically operated diagnostic testing apparatus and instruments for use in the fields of sclerotheraphy, phlebology, angiology proctology, interventional oncology, tumors, basal cell carcinoma, emphysema, varicose veins, arterio-venous malformations, oesophageal varices, hydroceles and skin complaints including psoriasis and eczema for laboratory or research use * ] ; all of the aforesaid goods being for use in relation to pharmaceutical, veterinary, surgical, medical, medical diagnostic, biotechnology, drug discovery or healthcare goods or services * | SECTION 71 - CANCELLED | — |
| 016 | Printed matter and printed publications, namely, books, manuals, brochures and other literature in the nature of pamphlets, [ printed periodicals, ] course materials in the nature of educational books, [ flash cards and ] worksheets, guide books, and user manuals and leaflets in the fields of healthcare, the use of pharmaceuticals [ and medical devices, ] medical research, [ surgery, ] medical science, medicine, patient care, medical diseases, disorders and related treatments; printed journals, printed periodicals, printed reports [ and printed questionnaires ] in the field of healthcare, pharmaceutical products, healthcare and medical diseases, disorders and related treatments, medicine, medical treatment and related hotline services, patient care, prescription drugs, ordering, prescribing, and dispensing practices of drugs, treatment and aftercare guidelines [ ; wallet cards in the nature of note cards that fold to fit neatly in a wallet and documents in the nature of hand-outs and paper identification cards all featuring personal and medical information concerning an individual's health condition; wallet cards in the nature of note cards that fold to fit neatly in a wallet and documents in the nature of hand-outs and paper identification cards all featuring contact information for a medical information hotline ] | SECTION 71 - CANCELLED | — |
| 035 | [ Business management; business administration; office functions; business administration services, namely, the registration, transcription and compilation of health, medical and personal information into computer databases; business administration services, namely, * the * collection, ] [storage,] [ management and retrieval of health, medical and personal information; ] membership services, namely, [ providing discounts and processing rebates in the field of healthcare and ] providing information in the field of [ discounts and ] rebates in the field of healthcare | SECTION 71 - CANCELLED | — |
| 036 | [ Insurance services, namely, claims administration, medical insurance claims processing, insurance tracking services, namely, providing information and on-line computer databases for the purpose of review and verification of Medicaid eligibility status and related information, medical insurance claims administration and medical insurance claims processing; Claims administration services in the field of health insurance, namely, claims tracking assistance services; Insurance claims processing, namely, processing of medical insurance and pharmaceutical claims and reimbursement payment processing in the field of medical insurance and pharmaceutical claims; Healthcare navigation services, namely, health insurance policy review services; health insurance claims negotiation and appeal services; providing educational information in the field of health insurance; providing counselling and consulting in the field of healthcare benefits ] | SECTION 71 - CANCELLED | — |
| 041 | Education, namely, developing, arranging and conducting educational conferences, seminars, workshops and programs and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals [ and medical devices ], medical research, [ surgery, ] medical science, medicine, medical diseases, disorders and related treatments; provision of educational content, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals [ and medical devices, ] medical research, [ surgery, ] medical science, medicine, medical diseases, disorders and related treatments; providing computer, electronic and online databases featuring information about medical education in the field of healthcare, medicine, medical treatment and patient care; training in the use and operation of pharmaceutical products, pharmaceutical preparations, [ radiopharmaceutical preparations, medical devices, medical imaging apparatus and medical research apparatus and ] consultation relating thereto; educational services, namely, conducting [ live and ] online seminars, [ classes, workshops, conferences, ] lectures, [ panel discussions, ] and training programs in the fields of healthcare, the use of pharmaceutical [ and medical devices ], medical research, [ surgery, ] medical science, medicine and medical diseases, disorders and related treatments; Educational services, namely, providing non-downloadable webinars in the fields of healthcare, the use of pharmaceuticals [ and medical devices ], medical research, [ surgery, ] medical science, medicine, medical diseases, disorders and related treatments; educational services, namely, conducting [ live and ] online seminars, [ classes, workshops, conferences, ] lectures, [ panel discussions ] and training in the field of health; educational services, namely, providing non-downloadable webinars in the field of health; education services, namely, conducting online [ and telephonic ] instruction and courses in the fields of health and medical issues | SECTION 71 - CANCELLED | — |
| 042 | [ * Electronic * Storage of health and/or medical and/or personal information * ; all of the aforesaid services being for use in relation to pharmaceutical, veterinary, surgical, medical, medical diagnostic, biotechnology, drug discovery or healthcare goods or services * ] | SECTION 71 - CANCELLED | — |
| 044 | Medical services; [ medical services relating to ultrasound waves to enhance drug delivery and medically activate drugs; medical services in the nature of dissolution of thrombotic blood clot material using catheters; ] providing medical information regarding medicine, medical treatment, patient care, pharmaceuticals, prescription drugs, [ medical devices, ] ordering, prescribing, and dispensing practices of drugs, treatment and aftercare via a website; [ medical and veterinary services, namely, diagnosis, assessment, treatment and aftercare in the fields of sclerotherapy, phlebology, angiology, proctology, interventional oncology, ablation of tumours using embolic beads, ablation of tumours using embolic radioactive beads, ablation of tumours using embolic drug eluting beads and ] [ emphysema ] [, and in connection with varicose veins, arterio-venous malformations, oesophageal varices, hydroceles and sterilisation treatment; medical analysis for the diagnosis and treatment of cancer, tumors, ] [ emphysema ] [, sclerotherapy, phlebology, angiology, proctology, varicose veins, arterio-venous malformations, oesophageal varices, sterilisation treatment, circulatory system conditions, and pulmonary and thoracic conditions; pharmacy advice in the nature of pharmaceutical and medical device advice; medical services for diagnosis in the fields of ] [ emphysema ] [, sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices, hydroceles and sterilisation treatment; medical health assessment services, namely, medical diagnosis of diseases and conditions in the fields of ] [ emphysema ] [, sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment * ; * ] [.] [ medical treatment of diseases and conditions in the fields of ] [ emphysema ] [, sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; medical after care services in the fields of ] [ emphysema ] [, sclerotherapy, phlebology, angiology and proctology and in particular, in relation to varicose veins, arterio-venous malformations, oesophageal varices and sterilisation treatment; advisory services relating to health and healthcare; ] advisory services relating to medicine and medical treatment and services; medical advisory services relating to patient care; [ conducting health assessment surveys, health risk assessment surveys, treatment outcome surveys and ] providing health advice and information services; [ conducting health assessment surveys, health risk assessment surveys, and treatment outcome surveys, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment information and health advice and information services; ] healthcare consultancy services; consultancy services relating to medical treatment; information services relating to healthcare and medical treatment; [ healthcare consultancy services, namely, providing a hotline for medical, counselling and nursing personnel; healthcare consultancy services, namely, providing patient and patient medical record information by hotline services; providing health and medical information by hotline services; ] advisory services relating to health and healthcare; advisory services relating to medicine and medical treatment and services; medical advisory services relating to patient care; [ medical equipment rental; ] advisory services relating to medical [ apparatus, instruments and ] preparations; advisory services relating to medical services *; * [.] providing medical advisory, consultancy and information services relating to the aforesaid services [ ; medical services relating to treatment of snakebite envenomation, digoxin or digitalis toxicity, methotrexate toxicity, fluorouracil toxicity and chemotherapy toxicity ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Protherics Medicines Development Limited
- Other trademarks owned by BTG International Limited
- Other trademarks owned by BTG International Limited
- Other trademarks owned by BTG International Limited
- Other trademarks owned by Protherics Medicines Development Limited
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BTG
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 13, 2026 | C71T | CANCELLED SECTION 71 | — |
| Mar 22, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jan 23, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 27, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 24, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 23, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| May 17, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 12, 2024 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 31, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 11, 2023 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 11, 2023 | INPC | INVALIDATION PROCESSED | — |
| Nov 24, 2023 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 24, 2023 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Mar 24, 2023 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Mar 24, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 21, 2022 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| May 9, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 9, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 9, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 9, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 9, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 9, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 8, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 2, 2021 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Sep 20, 2018 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Sep 16, 2018 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 16, 2018 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Dec 28, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 7, 2017 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Dec 7, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 13, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 23, 2017 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Mar 5, 2017 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 2, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 28, 2016 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Jun 27, 2016 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jun 27, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 27, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 23, 2016 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jun 22, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 6, 2016 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Apr 6, 2016 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Mar 22, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 21, 2016 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jan 5, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 5, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 4, 2016 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 16, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 16, 2015 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Dec 16, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 16, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 2, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 24, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 23, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 23, 2015 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 20, 2015 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Nov 12, 2015 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Oct 16, 2015 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jun 13, 2015 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Jun 2, 2015 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| May 25, 2015 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 25, 2015 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 25, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 15, 2015 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| May 2, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 1, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 1, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 1, 2015 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jan 3, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 16, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 16, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 12, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 11, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 1, 2014 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Nov 26, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 25, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 25, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 21, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 20, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |